SEC Form 4 · accession 0001645627-17-000043
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Apr 24, 2017
Accepted (ET)
Apr 27, 2017 · 12:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 24, 2017 | P | 1,000 | $0.0654 | A | 20,306,949 | D | |
| Common Stock | Apr 24, 2017 | P | 1,000 | $0.0654 | A | 20,307,949 | D | |
| Common Stock | Apr 24, 2017 | P | 1,000 | $0.0653 | A | 20,308,949 | D | |
| Common Stock | Apr 24, 2017 | P | 1,000 | $0.0654 | A | 20,309,949 | D | |
| Common Stock | Apr 24, 2017 | P | 1,000 | $0.065 | A | 20,310,949 | D | |
| Common Stock | Apr 24, 2017 | P | 1,000 | $0.065 | A | 20,311,949 | D | |
| Common Stock | Apr 24, 2017 | P | 1,000 | $0.065 | A | 20,312,949 | D | |
| Common Stock | Apr 24, 2017 | P | 1,000 | $0.0648 | A | 20,313,949 | D | |
| Common Stock | Apr 24, 2017 | P | 1,000 | $0.0653 | A | 20,314,949 | D | |
| Common Stock | Apr 24, 2017 | P | 1,000 | $0.0653 | A | 20,315,949 | D | |
| Common Stock | Apr 24, 2017 | P | 1,000 | $0.0653 | A | 20,316,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.064 | A | 20,317,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.064 | A | 20,318,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.066 | A | 20,319,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.068 | A | 20,320,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.066 | A | 20,321,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.066 | A | 20,322,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.0689 | A | 20,323,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.069 | A | 20,324,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.069 | A | 20,325,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.07 | A | 20,326,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.07 | A | 20,327,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.07 | A | 20,328,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.07 | A | 20,329,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.07 | A | 20,330,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.07 | A | 20,331,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.07 | A | 20,332,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.07 | A | 20,333,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.067 | A | 20,334,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.067 | A | 20,335,949 | D |
Table II — derivative securities
No Table II lines on this filing.